Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Read the Ars Technica artcle

Read the Ars Technica artcle

posted on Mar 13, 2005 07:26AM
I`m struck by the way they villify AMD for licencing the IP while ignoring the fact that Intel licnsed the IP from Moore/TPL.

What a bunch of Intel fanboys!!!!

PTSC fanboy.

Share
New Message
Please login to post a reply